Page last updated: 2024-10-23

bisbenzimidazole and Neuroectodermal Tumors, Primitive, Peripheral

bisbenzimidazole has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boschman, GA1
Rens, W1
Manders, EM1
Slater, RM1
Versteeg, R1
Aten, JA1

Other Studies

1 other study available for bisbenzimidazole and Neuroectodermal Tumors, Primitive, Peripheral

ArticleYear
Detection of recurrent chromosome abnormalities in Ewing's sarcoma and peripheral neuroectodermal tumor cells using bivariate flow karyotyping.
    Genes, chromosomes & cancer, 1992, Volume: 5, Issue:4

    Topics: Bisbenzimidazole; Bone Neoplasms; Chromomycin A3; Chromosome Aberrations; Chromosomes, Human, Pair 1

1992